The University of Adelaide and SA Health, will be conducting a Meningococcal B Vaccine Herd Immunity Study across the state during 2017 and 2018. This voluntary study will involve all students in Years 10, 11, 12 in 2017.
Students will be vaccinated with Meningococcal B Vaccine Bexsero, (2 doses, 1-2 months apart), free of charge. Schools will be randomly selected for students to be vaccinated in either 2017 or 2018. In addition, two throat swabs will be collected from participants over the two-year period.
In order for the program to be successful, and to provide clinical evidence into the effectiveness of the vaccine in the contest of the herd immunity, it is hoped that at least 80% of the state’s students will participate (approximately 44,000 students).
This study will have a global impact and will and inform policy makers around the Meningococcal B Vaccine herd immunity benefits and how this can reduce the spread of the bacteria from person to person.
All students in Years 10 to 12 will be offered the trial. Students will be eligible to participate once both parental and student consent has been gained. Consent forms will be sent home during Week 1 of term, and should be returned by Friday 17 February.
For further information, visit the study hub at www.bpartofit.com.au, or contact the City of Onkaparinga Immunisation Service on 8384 0666.